Free Theranos: Who Has Blood on Their Hands? (A) Case Study Solution | Assignment Help

MBA Staff Writer
Written by Gary F. Smith
Publish Date: 2024-12-03

Harvard Case - Theranos: Who Has Blood on Their Hands? (A)

"Theranos: Who Has Blood on Their Hands? (A)" Harvard business case study is written by Nien-he Hsieh, Christina R. Wing, Emilie Fournier, Anna Resman. It deals with the challenges in the field of Information Technology. The case study is 35 page(s) long and it was first published on : Feb 6, 2019

At Fern Fort University, we recommend a comprehensive investigation into Theranos's practices and a thorough review of its technology, business model, and leadership. This investigation should be conducted by an independent, qualified third party with expertise in healthcare, technology, and business ethics. The findings of this investigation should be made public to ensure accountability and transparency. Additionally, we recommend the implementation of stricter regulations for the development and deployment of innovative medical technologies to prevent similar situations from occurring in the future.

2. Background

Theranos, founded by Elizabeth Holmes, aimed to revolutionize blood testing by developing a proprietary technology that could perform a wide range of tests using a single drop of blood. The company attracted significant investment and media attention, becoming a darling of Silicon Valley. However, Theranos's claims were met with skepticism from industry experts, and concerns about the accuracy and validity of its technology grew. Eventually, a series of investigative reports revealed that the company had been exaggerating its capabilities and misleading investors and patients. Theranos was ultimately forced to shut down, and Holmes faced criminal charges for fraud.

The main protagonists in this case are Elizabeth Holmes, the founder and CEO of Theranos, and Sunny Balwani, the company's president and COO. Other key players include investors, board members, and employees who were involved in the development and promotion of the company's technology.

3. Analysis of the Case Study

This case study highlights several key issues related to innovation, corporate governance, and ethical decision-making.

Strategic Framework: We can analyze this case using Porter's Five Forces framework:

  • Threat of New Entrants: The blood testing industry is relatively mature, but Theranos's disruptive innovation presented a potential threat to established players.
  • Bargaining Power of Buyers: Patients have limited bargaining power as they rely on healthcare professionals for testing recommendations.
  • Bargaining Power of Suppliers: Theranos relied on a limited number of suppliers for components, potentially giving them leverage.
  • Threat of Substitutes: Existing blood testing methods provided a strong substitute for Theranos's technology.
  • Competitive Rivalry: Theranos faced intense competition from established players like Quest Diagnostics and LabCorp.

Financial Analysis: Theranos raised significant capital through venture funding, but its business model was based on unproven technology and lacked a clear path to profitability. The company's financial performance was opaque, and its valuation was inflated based on unrealistic projections.

Marketing Analysis: Theranos employed a sophisticated marketing strategy that emphasized its disruptive potential and the visionary leadership of Elizabeth Holmes. The company leveraged media attention and celebrity endorsements to build its brand image.

Operational Analysis: Theranos faced significant operational challenges in scaling up its technology and ensuring the accuracy and reliability of its tests. The company's reliance on proprietary technology and its lack of transparency created a culture of secrecy and hindered external scrutiny.

Ethical Analysis: The case study raises serious ethical concerns about Theranos's practices, including misleading investors, patients, and regulators about the capabilities of its technology. The company's culture of secrecy and its willingness to prioritize profit over patient safety are also concerning.

4. Recommendations

  1. Independent Investigation: A comprehensive and independent investigation should be conducted to determine the extent of Theranos's wrongdoing and the role of its leadership in the company's downfall. This investigation should involve experts in healthcare, technology, and business ethics.
  2. Regulatory Reform: The case study highlights the need for stronger regulations for the development and deployment of innovative medical technologies. These regulations should focus on ensuring transparency, accountability, and patient safety.
  3. Enhanced Corporate Governance: Companies like Theranos should be held to higher standards of corporate governance, including independent board oversight, robust financial reporting, and a culture of ethical decision-making.
  4. Increased Investor Due Diligence: Investors should exercise greater due diligence when evaluating companies with disruptive technologies. They should focus on understanding the underlying science, the company's financial performance, and the potential risks involved.
  5. Public Education: The public should be educated about the importance of critical thinking and skepticism when evaluating new technologies, especially in the healthcare industry.

5. Basis of Recommendations

These recommendations are based on the following considerations:

  1. Core Competencies and Consistency with Mission: The recommendations align with the core competencies of independent investigators, regulators, and investors in ensuring ethical and responsible innovation.
  2. External Customers and Internal Clients: The recommendations prioritize the interests of patients, investors, and the public by promoting transparency, accountability, and patient safety.
  3. Competitors: The recommendations aim to create a level playing field for all companies in the healthcare industry by ensuring that all players adhere to the same ethical and regulatory standards.
  4. Attractiveness - Quantitative Measures: While it is difficult to quantify the benefits of improved regulation and ethical conduct, the recommendations are expected to lead to a more robust and trustworthy healthcare industry.

6. Conclusion

The Theranos case study serves as a cautionary tale about the dangers of unchecked innovation, corporate greed, and ethical lapses. The company's failure highlights the importance of transparency, accountability, and rigorous scrutiny in the development and deployment of new technologies, particularly in the healthcare industry. By implementing the recommendations outlined above, we can work to prevent similar situations from occurring in the future.

7. Discussion

Alternatives Not Selected:

  • Ignoring the issue: This would have allowed Theranos to continue operating with its flawed technology and potentially harm patients.
  • Internal investigation: This would have lacked the independence and objectivity needed to ensure a fair and thorough investigation.

Risks and Key Assumptions:

  • Implementation challenges: Implementing regulatory reforms and promoting ethical conduct in the healthcare industry can be challenging and time-consuming.
  • Unintended consequences: New regulations may inadvertently stifle innovation or create barriers to entry for new companies.
  • Investor behavior: Investors may not always exercise sufficient due diligence, even with stricter regulations in place.

8. Next Steps

  1. Form an independent investigative panel: Within the next 6 months, assemble a panel of experts to conduct a thorough investigation into Theranos's practices.
  2. Develop new regulations: Within the next 12 months, work with stakeholders to develop new regulations for the development and deployment of innovative medical technologies.
  3. Educate the public: Launch a public awareness campaign within the next year to educate the public about the importance of critical thinking and skepticism when evaluating new technologies.

By taking these steps, we can work to ensure that the Theranos case study serves as a valuable learning experience and leads to a more responsible and ethical healthcare industry.

Hire an expert to write custom solution for HBR Information Technology case study - Theranos: Who Has Blood on Their Hands? (A)

Case Description

This case covers the rise and fall of Theranos, the company founded by Elizabeth Holmes in 2004 to revolutionize the blood testing industry by creating a device that could provide from a small finger prick the same results and accuracy as intravenous blood draws. As founder and CEO, Holmes was hailed as the most successful female tech entrepreneur ever. In October 2015, however, a Wall Street Journal article exposed internal struggles and questioned the startup's trajectory. Subsequent investigations revealed that Theranos, despite commercial operations in 40 retail locations, lacked a functioning product. Set in 2017, the (A) Case opens with Theranos' motion to dismiss the class action lawsuit filed by two investors who claimed that Theranos and its officers had violated California's securities law and engaged in fraud.

🎓 Struggling with term papers, essays, or Harvard case studies? Look no further! Fern Fort University offers top-quality, custom-written solutions tailored to your needs. Boost your grades and save time with expertly crafted content. Order now and experience academic excellence! 🌟📚 #MBA #HarvardCaseStudies #CustomEssays #AcademicSuccess #StudySmart Write my custom case study solution for Harvard HBR case - Theranos: Who Has Blood on Their Hands? (A)

Hire an expert to write custom solution for HBR Information Technology case study - Theranos: Who Has Blood on Their Hands? (A)

Theranos: Who Has Blood on Their Hands? (A) FAQ

What are the qualifications of the writers handling the "Theranos: Who Has Blood on Their Hands? (A)" case study?

Our writers hold advanced degrees in their respective fields, including MBAs and PhDs from top universities. They have extensive experience in writing and analyzing complex case studies such as " Theranos: Who Has Blood on Their Hands? (A) ", ensuring high-quality, academically rigorous solutions.

How do you ensure confidentiality and security in handling client information?

We prioritize confidentiality by using secure data encryption, access controls, and strict privacy policies. Apart from an email, we don't collect any information from the client. So there is almost zero risk of breach at our end. Our financial transactions are done by Paypal on their website so all your information is very secure.

What is Fern Fort Univeristy's process for quality control and proofreading in case study solutions?

The Theranos: Who Has Blood on Their Hands? (A) case study solution undergoes a rigorous quality control process, including multiple rounds of proofreading and editing by experts. We ensure that the content is accurate, well-structured, and free from errors before delivery.

Where can I find free case studies solution for Harvard HBR Strategy Case Studies?

At Fern Fort University provides free case studies solutions for a variety of Harvard HBR case studies. The free solutions are written to build "Wikipedia of case studies on internet". Custom solution services are written based on specific requirements. If free solution helps you with your task then feel free to donate a cup of coffee.

I’m looking for Harvard Business Case Studies Solution for Theranos: Who Has Blood on Their Hands? (A). Where can I get it?

You can find the case study solution of the HBR case study "Theranos: Who Has Blood on Their Hands? (A)" at Fern Fort University.

Can I Buy Case Study Solution for Theranos: Who Has Blood on Their Hands? (A) & Seek Case Study Help at Fern Fort University?

Yes, you can order your custom case study solution for the Harvard business case - "Theranos: Who Has Blood on Their Hands? (A)" at Fern Fort University. You can get a comprehensive solution tailored to your requirements.

Can I hire someone only to analyze my Theranos: Who Has Blood on Their Hands? (A) solution? I have written it, and I want an expert to go through it.

🎓 Struggling with term papers, essays, or Harvard case studies? Look no further! Fern Fort University offers top-quality, custom-written solutions tailored to your needs. Boost your grades and save time with expertly crafted content. Order now and experience academic excellence! 🌟📚 #MBA #HarvardCaseStudies #CustomEssays #AcademicSuccess #StudySmart Pay an expert to write my HBR study solution for the case study - Theranos: Who Has Blood on Their Hands? (A)

Where can I find a case analysis for Harvard Business School or HBR Cases?

You can find the case study solution of the HBR case study "Theranos: Who Has Blood on Their Hands? (A)" at Fern Fort University.

Which are some of the all-time best Harvard Review Case Studies?

Some of our all time favorite case studies are -

Can I Pay Someone To Solve My Case Study - "Theranos: Who Has Blood on Their Hands? (A)"?

Yes, you can pay experts at Fern Fort University to write a custom case study solution that meets all your professional and academic needs.

Do I have to upload case material for the case study Theranos: Who Has Blood on Their Hands? (A) to buy a custom case study solution?

We recommend to upload your case study because Harvard HBR case studies are updated regularly. So for custom solutions it helps to refer to the same document. The uploading of specific case materials for Theranos: Who Has Blood on Their Hands? (A) ensures that the custom solution is aligned precisely with your needs. This helps our experts to deliver the most accurate, latest, and relevant solution.

What is a Case Research Method? How can it be applied to the Theranos: Who Has Blood on Their Hands? (A) case study?

The Case Research Method involves in-depth analysis of a situation, identifying key issues, and proposing strategic solutions. For "Theranos: Who Has Blood on Their Hands? (A)" case study, this method would be applied by examining the case’s context, challenges, and opportunities to provide a robust solution that aligns with academic rigor.

"I’m Seeking Help with Case Studies,” How can Fern Fort University help me with my case study assignments?

Fern Fort University offers comprehensive case study solutions, including writing, analysis, and consulting services. Whether you need help with strategy formulation, problem-solving, or academic compliance, their experts are equipped to assist with your assignments.

Achieve academic excellence with Fern Fort University! 🌟 We offer custom essays, term papers, and Harvard HBR business case studies solutions crafted by top-tier experts. Experience tailored solutions, uncompromised quality, and timely delivery. Elevate your academic performance with our trusted and confidential services. Visit Fern Fort University today! #AcademicSuccess #CustomEssays #MBA #CaseStudies

How do you handle tight deadlines for case study solutions?

We are adept at managing tight deadlines by allocating sufficient resources and prioritizing urgent projects. Our team works efficiently without compromising quality, ensuring that even last-minute requests are delivered on time

What if I need revisions or edits after receiving the case study solution?

We offer free revisions to ensure complete client satisfaction. If any adjustments are needed, our team will work closely with you to refine the solution until it meets your expectations.

How do you ensure that the case study solution is plagiarism-free?

All our case study solutions are crafted from scratch and thoroughly checked using advanced plagiarism detection software. We guarantee 100% originality in every solution delivered

How do you handle references and citations in the case study solutions?

We follow strict academic standards for references and citations, ensuring that all sources are properly credited according to the required citation style (APA, MLA, Chicago, etc.).

Hire an expert to write custom solution for HBR Information Technology case study - Theranos: Who Has Blood on Their Hands? (A)

Top Sellers

Most Read

Referrences & Bibliography for SWOT Analysis | SWOT Matrix | Strategic Management

1. Andrews, K. R. (1980). The concept of corporate strategy. Harvard Business Review, 61(3), 139-148.

2. Ansoff, H. I. (1957). Strategies for diversification. Harvard Business Review, 35(5), 113-124.

3. Brandenburger, A. M., & Nalebuff, B. J. (1995). The right game: Use game theory to shape strategy. Harvard Business Review, 73(4), 57-71.

4. Christensen, C. M., & Raynor, M. E. (2003). Why hard-nosed executives should care about management theory. Harvard Business Review, 81(9), 66-74.

5. Christensen, C. M., & Raynor, M. E. (2003). The innovator's solution: Creating and sustaining successful growth. Harvard Business Review Press.

6. D'Aveni, R. A. (1994). Hypercompetition: Managing the dynamics of strategic maneuvering. Harvard Business Review Press.

7. Ghemawat, P. (1991). Commitment: The dynamic of strategy. Harvard Business Review, 69(2), 78-91.

8. Ghemawat, P. (2002). Competition and business strategy in historical perspective. Business History Review, 76(1), 37-74.

9. Hamel, G., & Prahalad, C. K. (1990). The core competence of the corporation. Harvard Business Review, 68(3), 79-91.

10. Kaplan, R. S., & Norton, D. P. (1992). The balanced scorecard--measures that drive performance. Harvard Business Review, 70(1), 71-79.

11. Kim, W. C., & Mauborgne, R. (2004). Blue ocean strategy. Harvard Business Review, 82(10), 76-84.

12. Kotter, J. P. (1995). Leading change: Why transformation efforts fail. Harvard Business Review, 73(2), 59-67.

13. Mintzberg, H., Ahlstrand, B., & Lampel, J. (2008). Strategy safari: A guided tour through the wilds of strategic management. Harvard Business Press.

14. Porter, M. E. (1979). How competitive forces shape strategy. Harvard Business Review, 57(2), 137-145.

15. Porter, M. E. (1980). Competitive strategy: Techniques for analyzing industries and competitors. Simon and Schuster.

16. Porter, M. E. (1985). Competitive advantage: Creating and sustaining superior performance. Free Press.

17. Prahalad, C. K., & Hamel, G. (1990). The core competence of the corporation. Harvard Business Review, 68(3), 79-91.

18. Rumelt, R. P. (1979). Evaluation of strategy: Theory and models. Strategic Management Journal, 1(1), 107-126.

19. Rumelt, R. P. (1984). Towards a strategic theory of the firm. Competitive Strategic Management, 556-570.

20. Teece, D. J., Pisano, G., & Shuen, A. (1997). Dynamic capabilities and strategic management. Strategic Management Journal, 18(7), 509-533.